SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-160851
Filing Date
2009-07-31
Accepted
2009-07-31 16:27:41
Documents
5
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 626746
2 AMENDED AND RESTATED SEVERANCE PLAN AND SUMMARY PLAN DESCRIPTION dex101.htm EX-10.1 97761
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 7677
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 7661
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex321.htm EX-32.1 3524
  Complete submission text file 0001193125-09-160851.txt   744747
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 09977696
SIC: 2834 Pharmaceutical Preparations